China's SeekIn gets CE Mark approval for SeekInCare Pan Cancer early detection test

China |  News | 0 Comment | 08 Mar, 2022

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...Read more

China approves phase II trial of Akeso's cancer drug

China |  News | 0 Comment | 08 Mar, 2022

Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...Read more

WuXi ATU announces launch of TESSA Technology

China |  News | 0 Comment | 08 Mar, 2022

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...Read more

Singleron extends reach outside China, strengthens expertise in translational & clinical research

China |  News | 0 Comment | 08 Mar, 2022

Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platf...Read more

AnchorDx appoints Dr. Marina Bibikova as Chief Scientific Officer

China |  News | 0 Comment | 07 Mar, 2022

AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announc...Read more

111, Inc & Beilin Pharma lay focus on digital marketing of Chinese patent medicines

China |  News | 0 Comment | 07 Mar, 2022

111, Inc., a leading tech-enabled healthcare platform company in China, has signed a strategic cooperation agreement on ...Read more

I-Mab receives FDA orphan drug designation for cancer drug

China |  News | 0 Comment | 04 Mar, 2022

China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...Read more

China-based startup InxMed raises $50 M in Series B Financing

China |  News | 0 Comment | 04 Mar, 2022

InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...Read more

Overland Pharmaceuticals Appoints Dr. Xun Liu as Chief Technology Officer

China |  News | 0 Comment | 03 Mar, 2022

Overland Pharmaceuticals, a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worl...Read more

China's Adagene partners with French firm Sanofi for Immuno-Oncology

China |  News | 0 Comment | 03 Mar, 2022

China's Adagene,  a company transforming the discovery and development of antibody-based therapies, has announced a...Read more

China approves Phase II clinical trial of InnoCare's cancer drug

China |  News | 0 Comment | 03 Mar, 2022

InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...Read more

IASO Bio strengthens manufacturing of CAR-T cell therapy products in China

China |  News | 0 Comment | 02 Mar, 2022

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing i...Read more

Huadong becomes strategic partner in Asia for Heidelberg Pharma, strikes deal worth $0.9B

China |  News | 0 Comment | 01 Mar, 2022

German firm Heidelberg Pharma AG and Huadong Medicine in China have entered into a strategic partner...Read more

China's CANbridge offers treatment for rare liver disease Alagille Syndrome

China |  News | 0 Comment | 28 Feb, 2022

CANbridge Pharmaceuticals, Inc. has announced that CAN108 (maralixibat), a treatment for Alagille syndrome (ALGS), has b...Read more

Prenetics, ACON Bio to launch Flowflex COVID-19 at-home test in Hong Kong

China |  News | 0 Comment | 25 Feb, 2022

Prenetics Group has partnered with ACON Bio to launch the Flowflex SARS-CoV-2 Antigen Rapid Test Kit in Hong Kong. ...Read more

Peli BioThermal opens first network station in China

China |  News | 0 Comment | 24 Feb, 2022

Peli BioThermal, the life science industry’s cold chain partner from discovery to distribution, announces the open...Read more

China approves world first clinical trial for 3D bio-printed stem cell vascular grafts

China |  News | 0 Comment | 22 Feb, 2022

Revotek has received clearance from the National Health Commission of China to begin a clinical study in the W...Read more

China approves CanSinoBIO's Convidecia as heterologous booster for COVID-19

China |  News | 0 Comment | 21 Feb, 2022

CanSino Biologics Inc. has announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)...Read more